CIBC World Upgrades Atrix Laboratories

Analyst Mara Goldstein raises her rating amid the positive catalyst generated by the FDA's approval of the company's generic version of Benzamycin acne gel

Atrix Laboratories (ATRX ) says the Food and Drug Administration reversed its decicion and approved its generic version of an acne gel. CIBC World upgraded the stock.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.